Lv1
100 积分 2024-11-12 加入
Three-year follow-up analysis of axicabtagene ciloleucel in relapsed/refractory indolent non-Hodgkin lymphoma (ZUMA-5)
6小时前
待确认
The future of follicular lymphoma management: strategies on the horizon
1天前
已完结
Long-term 3-year follow-up of mosunetuzumab in relapsed or refractory follicular lymphoma after ≥2 prior therapies
1天前
已关闭
Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial
3天前
已完结
R‐CHOP treatment for patients with advanced follicular lymphoma: Over 15‐year follow‐up of JCOG0203
8天前
已完结
Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma
13天前
已完结
Tafasitamab, lenalidomide, and rituximab in relapsed or refractory follicular lymphoma (inMIND): a global, phase 3, randomised controlled trial
16天前
已完结
Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial
16天前
已关闭
Efficacy and safety of first-line maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-cell lung cancer (IMforte): a randomised, multicentre, open-label, phase 3 trial
19天前
已完结
Efficacy and safety of first-line maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-cell lung cancer (IMforte): a randomised, multicentre, open-label, phase 3 trial
19天前
已关闭
激光增材制造高温合金抗开裂行为 研究进展
4个月前
已采纳
Characterization of canine tumor-infiltrating leukocyte transcriptomic signatures reveals conserved expression patterns with human osteosarcoma
4个月前
已采纳
Toward an Intersectional Theory of Practice: Integrating Pierre Bourdieu’s and Patricia H. Collins’s Thought
4个月前
已采纳
Analysis and prediction of multi-pass snake hot rolling for 7075 aluminum alloy thick plate
4个月前
已采纳
皖公网安备34019202002308
